Latest news
Stay up to date on the latest activities and publications from hera
Archive
- 2023
- Aarti Patel
- Accountability
- Afghanistan
- Africa
- Alejandra Martinez
- Alice Behrendt
- Alice Peschiutta
- Angola
- Anne Buve
- Argentina
- Asia Pacific
- Assessment
- Bangladesh
- Basic Health Services / Primary health care
- Behaviour Change Communication
- Belize
- Benin (Dahomey)
- Botswana
- Cabo Verde
- Calvin Tonga
- Caribbean
- Central Asia
- Chad
- Child Protection
- Child and adolescent health
- Children
- Cholera
- Communicable diseases (CD)
- Community Engagement
- Community Health Workers
- Comoros
- Costing studies
- Country Capacity
- Covid-19
- Crisis Management
- Côte d'Ivoire
- DESIP
- DRC
- Demand side financing
- Development
- Development Cooperation
- Dia Timmermans
- Diarrhoea
- Drug Pricing
- Drug Regulatory Authority
- Ebola
- Ecuador
- Ed Vreeke
- Education
Mid-term review of the EU/ACP/WHO Renewed Partnership for strengthening pharmaceutical systems and improving access to quality medicines in 15 African ACP Countries
The “The Renewed EU/ACP/WHO Partnership” (RP) was a four year programme (October 2012 – September 2016) with the overall objective to contribute to the achievement of health-related MDGs and to universal health coverage in African ACP countries by improving the availability, affordability and use of safe, effective and quality assured essential medicines for the treatment of priority acute and non-communicable diseases.
SADC Feasibility Study on Regional Manufacturing of Medicines and Health Commodities
Assess the feasibility of the local production of essential medicines especially those related to the three communicable diseases, namely HIV and AIDS, TB and Malaria as well as the production of health commodities for the three diseases.
Assessing the Impact: BMGF & DFID's Reproductive Health Programmes in Low- and Middle-Income Countries
In an effort to promote reproductive health and accessibility to quality-assured reproductive health commodities in low- and middle-income countries, the Bill & Melinda Gates Foundation (BMGF) and the Department for International Development (DFID), now known as the Foreign, Commonwealth & Development Office (FCDO), rolled out two independent, yet complementary, programmes geared towards ensuring hormonal contraceptives become more readily available, of high quality and affordable.